Controlled Drugs
Handling controlled drugs requires precision, security, and in-depth regulatory knowledge. Our facilities in Athens, Kawagoe, and Livron offer specialized services to manage these essential yet stringent requirements. We ensure the safety, security, and regulatory compliance of pharmaceutical products containing controlled substances, including OxyContin, through meticulous planning and adherence to regulatory standards.
Our services include:
- Secure Storage Practices: We implement robust measures to ensure the secure storage of controlled drugs.
- Detailed Documentation: Comprehensive tracking and documentation systems to monitor controlled substances.
- Rigorous Tracking and Record-Keeping: Advanced systems for meticulous tracking and record-keeping of controlled drugs.
- Regular Inventory Management Checks: Routine checks to maintain accurate inventory of controlled drugs and ensure compliance.
- Quality Control Procedures: Stringent quality control to uphold the integrity of controlled drugs.
- Comprehensive Oversight: From procurement to distribution, our approach involves strict adherence to regulatory requirements, ensuring secure handling of OxyContin and other controlled substances, with continuous monitoring to mitigate risk and maintain standards.
Our commitment to controlled drugs management ensures that all procedures align with regulatory standards, offering both security and compliance throughout the entire process.
Our Network for Controlled Drugs Handling
Our state-of-the-art manufacturing site specialises in ampoules, tablets and visual inspection services. We offer excellent customer service in English and Japanese. It has one of the largest cold storage warehouses in Japan.
⟶
With over 100 years of experience, Adragos Livron focuses on sterile liquids and suppositories manufacturing. We handle more than 100 molecules and provide stability studies, narcotics handling and analytical testing services.
⟶
With more than 3,000 sqm of R&D facilities, Adragos Athens specialises in the development of Value Added Medicines and has been recently upgraded with HPAPI capabilities.
